Top Brain-Computer Interfaces companies

The 5 key players our Brain-Computer Interfaces report profiles, and other companies free public records show in this market.

Key players in Brain-Computer Interfaces

In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.

Key players in the Brain-Computer Interfaces market
#CompanyWebsiteOur reports
1 Neuralink — 33 reports
2 Synchron — 33 reports
3 Blackrock Neurotech — 33 reports
4 Precision Neuroscience — 33 reports
5 g.tec medical engineering — 33 reports

Also active in Brain-Computer Interfaces

Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.

Also active in Brain-Computer Interfaces, from free public records
CompanyWhere public records show them
Cognixion
Noah Tech, Corp.

Source: ClinicalTrials.gov, Active studies (recruiting, about to start or running) each company leads, found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

Top trial sponsors in Brain-Computer Interfaces

Companies leading the most active studies found with this market's trial search, worldwide (key players included).

  1. Neuralink 6 active trials on ClinicalTrials.gov (opens in a new tab)
  2. Cognixion 3 active trials on ClinicalTrials.gov (opens in a new tab)
  3. Noah Tech, Corp. 2 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

Brain-Computer Interfaces reports by place

All 33 places for Brain-Computer Interfaces

Get the full Brain-Computer Interfaces report

Company profiles, market shares and strategies come with the full report, with researched size, forecast, growth and segments.

Key players are our report's research. Other companies and trial counts come from free public records, each with its source. Acuitas market figures are not published on this page.